Search

everythinglearnresearchcommunity

for

Search:↓

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Mutations in certain receptors can cause diseases and offer new treatment options.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Anabolic steroid users may face higher risk of severe COVID-19.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Certain Dibenzo derivatives may help treat prostate cancer.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Dutasteride and finasteride affect different cell types differently.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Possible link between androgens and COVID-19 severity; more research needed.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.